Pain in Parkinson's disease

Area of Science:

• Neurology
• Pain Medicine
• Quality of Life Research

Background:

• Nonmotor symptoms, particularly pain, are increasingly recognized as significant contributors to reduced health-related quality of life in Parkinson disease (PD).
• Pain in PD is diverse, encompassing musculoskeletal, dystonic, radicular neuropathic, and central pain subtypes, with variable onset relative to motor symptoms.
• PD-associated pain is frequently under-recognized and inadequately treated, highlighting a critical gap in patient care.

Purpose of the Study:

• To review the current understanding of pain in Parkinson disease, including its classification, clinical presentation, and impact on quality of life.
• To explore the therapeutic strategies for managing different pain subtypes in PD.
• To discuss the insights gained into the pathogenesis of pain in PD and identify areas for future research.

Main Methods:

• Literature review of studies on pain in Parkinson disease.
• Analysis of pain classification, onset, and impact on quality of life.
• Evaluation of treatment modalities including dopaminergic therapy, botulinum toxin, and deep brain stimulation (DBS).

Main Results:

• Pain in PD manifests in various forms and can precede motor symptoms.
• Levodopa-related dystonia and PD-associated rigidity/akinesia may respond to dopaminergic medication.
• Botulinum toxin injections are effective for focal dystonia, and DBS has shown potential benefits for pain and dysesthesia.

Conclusions:

• Pain is a complex and often undertreated symptom in Parkinson disease, significantly affecting quality of life.
• Current therapeutic approaches offer partial relief, with dopaminergic medication, botulinum toxin, and DBS showing promise for specific pain types.
• Further research into the precise mechanisms of pain processing and modulation in PD is needed for improved management strategies.